185 related articles for article (PubMed ID: 12798396)
1. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
Goerres GW; Schmid DT; Grätz KW; von Schulthess GK; Eyrich GK
Oral Oncol; 2003 Sep; 39(6):547-51. PubMed ID: 12798396
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
[TBL] [Abstract][Full Text] [Related]
3. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
Stuckensen T; Kovács AF; Adams S; Baum RP
J Craniomaxillofac Surg; 2000 Dec; 28(6):319-24. PubMed ID: 11465137
[TBL] [Abstract][Full Text] [Related]
4. Value of FDG PET/CT in staging of oral cancer: four simultaneous primary malignancies.
Linz C; Müller-Richter UD; Kircher S; Lapa C; Bluemel C
Clin Nucl Med; 2015 May; 40(5):455-7. PubMed ID: 25742223
[TBL] [Abstract][Full Text] [Related]
5. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
Meltzer CC; Luketich JD; Friedman D; Charron M; Strollo D; Meehan M; Urso GK; Dachille MA; Townsend DW
Clin Nucl Med; 2000 Nov; 25(11):882-7. PubMed ID: 11079584
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
7. The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.
Nakasone Y; Inoue T; Oriuchi N; Takeuchi K; Negishi A; Endo K; Mogi K
Ann Nucl Med; 2001 Dec; 15(6):505-12. PubMed ID: 11831398
[TBL] [Abstract][Full Text] [Related]
8. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
[TBL] [Abstract][Full Text] [Related]
9. A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography.
Hyde NC; Prvulovich E; Newman L; Waddington WA; Visvikis D; Ell P
Oral Oncol; 2003 Jun; 39(4):350-60. PubMed ID: 12676254
[TBL] [Abstract][Full Text] [Related]
10. Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management.
Arya S; Rane P; Deshmukh A
Clin Radiol; 2014 Sep; 69(9):916-30. PubMed ID: 24908285
[TBL] [Abstract][Full Text] [Related]
11. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
Myers LL; Wax MK
J Otolaryngol; 1998 Dec; 27(6):342-7. PubMed ID: 9857320
[TBL] [Abstract][Full Text] [Related]
14. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
[TBL] [Abstract][Full Text] [Related]
15. Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Kitagawa Y; Nishizawa S; Sano K; Sadato N; Maruta Y; Ogasawara T; Nakamura M; Yonekura Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Feb; 93(2):202-7. PubMed ID: 11862212
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma.
Stoeckli SJ; Steinert H; Pfaltz M; Schmid S
Head Neck; 2002 Apr; 24(4):345-9. PubMed ID: 11933176
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
Pentenero M; Cistaro A; Brusa M; Ferraris MM; Pezzuto C; Carnino R; Colombini E; Valentini MC; Giovanella L; Spriano G; Gandolfo S
Head Neck; 2008 Nov; 30(11):1488-96. PubMed ID: 18767178
[TBL] [Abstract][Full Text] [Related]
18. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
19. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
[TBL] [Abstract][Full Text] [Related]
20. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
Schmid DT; Stoeckli SJ; Bandhauer F; Huguenin P; Schmid S; von Schulthess GK; Goerres GW
Laryngoscope; 2003 May; 113(5):888-91. PubMed ID: 12792328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
